Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-15 Option Award |
2025-03-18 8:00 pm |
N/A N/A |
Beta Bionics Inc. | BBNX | Palasis Maria Director |
11,247 | $0 | 11,247 (Direct) |
View |
2025-01-31 Option Award |
2025-02-03 8:30 pm |
N/A 2033-01-24 |
Beta Bionics Inc. | BBNX | Palasis Maria Director |
9,137 | $0 | 9,137 (Direct) |
View |
Ownership |
2025-01-29 9:40 pm |
N/A 2033-01-24 |
Beta Bionics Inc. | BBNX | Palasis Maria Director |
0 | $0 | 9,137 (Direct) |
View |
2025-01-08 Option Award |
2025-01-10 4:15 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
800,000 | $0 | 1,100,000 (Direct) |
View |
2024-12-09 Option Award |
2024-12-11 6:54 pm |
N/A 2034-03-20 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
183,333 | $0 | 183,333 (Direct) |
View |
2024-10-16 Option Award |
2024-10-18 4:05 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
300,000 | $0 | 300,000 (Direct) |
View |
2024-03-18 Option Award |
2024-03-20 7:20 pm |
N/A 2034-03-17 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
2023-06-15 Option Award(A) |
2023-07-12 6:36 pm |
N/A 2033-06-14 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
150,000 | $0 | 150,000 (Direct) |
View |
2023-06-15 Option Award |
2023-06-26 5:39 pm |
N/A 2023-06-14 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
150,000 | $0 | 150,000 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 5:09 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
250,000 | $0 | 250,000 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:12 pm |
N/A 2032-02-15 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
175,000 | $0 | 175,000 (Direct) |
View |
2022-02-12 Option Award |
2022-02-15 9:31 pm |
N/A 2032-02-11 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
127,400 | $0 | 127,400 (Direct) |
View |
2021-02-08 Option Award |
2021-02-10 4:05 pm |
N/A 2031-02-07 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
120,000 | $0 | 120,000 (Direct) |
View |
2020-04-30 Option Award |
2020-05-01 6:36 pm |
N/A 2030-04-29 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
326,303 | $0 | 326,303 (Direct) |
View |
Ownership |
2020-04-30 7:03 pm |
N/A 2021-11-16 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
0 | $0 | 343,322 (Direct) |
View |